Insider · CIK 0001640069

Burstein Jennifer

Reports to the SEC for 2 companies · BEDFORD, MA

sec.gov

Transactions

Companies

Filings

CIK

0001640069

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-03	STOKStoke Therapeutics, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+17.8K sh	—	—	17,786
2025-06-03	STOKStoke Therapeutics, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+29.7K sh	—	—	29,747
2024-06-05	STOKStoke Therapeutics, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+7,639 sh	—	—	7,639
2023-06-13	STOKStoke Therapeutics, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+19.4K sh	—	—	19,441
2022-06-07	STOKStoke Therapeutics, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+21K sh	—	—	21,000
2021-06-08	STOKStoke Therapeutics, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+11.7K sh	—	—	11,650
2020-06-03	STOKStoke Therapeutics, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+14.8K sh	—	—	14,777
2019-09-10	STOKStoke Therapeutics, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+29.6K sh	—	—	29,555
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Senior VP of Finance	DDisposition to Issuer	−20K sh	$235.00	−$4.7M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Senior VP of Finance	DDisposition to Issuer	−12K sh	$235.00	−$2.82M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Senior VP of Finance	DDisposition to Issuer	−17.5K sh	$235.00	−$4.11M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Senior VP of Finance	DDisposition to Issuer	−28K sh	$235.00	−$6.58M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Senior VP of Finance	DDisposition to Issuer	−28K sh	$235.00	−$6.58M	0
2019-02-15	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Senior VP of Finance	DDisposition to Issuer	−40K sh	$235.00	−$9.4M	0
2019-01-02	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)A Award	Senior VP of Finance	AAward	+20K sh	—	—	20,000
2018-12-11	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Senior VP of Finance	MExercise/Conversion	−1,250 sh	—	—	17,500
2018-12-11	Loxo Oncology, Inc.M Exercise/Conversion	Senior VP of Finance	MExercise/Conversion	+1,250 sh	$11.35	+$14.2K	1,250
2018-12-11	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−100 sh	$139.36	−$13.9K	100
2018-12-11	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−100 sh	$140.48	−$14K	0
2018-12-11	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−263 sh	$137.88	−$36.3K	200
2018-12-11	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−200 sh	$135.69	−$27.1K	1,050
2018-12-11	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−587 sh	$136.98	−$80.4K	463
2018-12-10	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−100 sh	$136.04	−$13.6K	0
2018-12-10	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−100 sh	$133.34	−$13.3K	650
2018-12-10	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Senior VP of Finance	MExercise/Conversion	−1,250 sh	—	—	18,750
2018-12-10	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−550 sh	$134.71	−$74.1K	100
2018-12-10	Loxo Oncology, Inc.M Exercise/Conversion	Senior VP of Finance	MExercise/Conversion	+1,250 sh	$11.35	+$14.2K	1,250
2018-12-10	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−100 sh	$130.79	−$13.1K	1,150
2018-12-10	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−400 sh	$132.44	−$53K	750
2018-11-27	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Senior VP of Finance	MExercise/Conversion	−1,250 sh	—	—	20,000
2018-11-27	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−100 sh	$151.55	−$15.2K	0
2018-11-27	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−100 sh	$148.20	−$14.8K	100
2018-11-27	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−100 sh	$147.09	−$14.7K	200
2018-11-27	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−200 sh	$143.84	−$28.8K	300
2018-11-27	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−200 sh	$140.94	−$28.2K	500
2018-11-27	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−350 sh	$138.95	−$48.6K	700
2018-11-27	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−200 sh	$137.89	−$27.6K	1,050
2018-11-27	Loxo Oncology, Inc.M Exercise/Conversion	Senior VP of Finance	MExercise/Conversion	+1,250 sh	$11.35	+$14.2K	1,250
2018-11-26	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−500 sh	$151.57	−$75.8K	750
2018-11-26	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Senior VP of Finance	MExercise/Conversion	−1,250 sh	—	—	21,250
2018-11-26	Loxo Oncology, Inc.M Exercise/Conversion	Senior VP of Finance	MExercise/Conversion	+1,250 sh	$11.35	+$14.2K	1,250
2018-11-26	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−100 sh	$156.04	−$15.6K	0
2018-11-26	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−300 sh	$155.13	−$46.5K	100
2018-11-26	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−100 sh	$153.30	−$15.3K	400
2018-11-26	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−250 sh	$152.39	−$38.1K	500
2018-10-04	Loxo Oncology, Inc.M Exercise/Conversion	Senior VP of Finance	MExercise/Conversion	+1,250 sh	$11.35	+$14.2K	1,250
2018-10-04	Loxo Oncology, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Senior VP of Finance	MExercise/Conversion	−1,250 sh	—	—	22,500
2018-10-04	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−539 sh	$161.22	−$86.9K	711
2018-10-04	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−200 sh	$165.05	−$33K	0
2018-10-04	Loxo Oncology, Inc.S Sale	Senior VP of Finance	SSale	−311 sh	$162.54	−$50.5K	400

Recent filings

Accepted (ET)
Jun 54
Burstein Jennifer0001640069-26-000002
SEC(opens sec.gov)
Jun 44
Burstein Jennifer0001415889-25-015695
SEC(opens sec.gov)
Jun 74
Burstein Jennifer0001415889-24-015976
SEC(opens sec.gov)
Jun 154
Burstein Jennifer0001209191-23-037529
SEC(opens sec.gov)
Jun 84
Burstein Jennifer0001209191-22-035078
SEC(opens sec.gov)
Jun 254
Burstein Jennifer0001209191-21-043329
SEC(opens sec.gov)
Jun 54
Burstein Jennifer0001209191-20-034723
SEC(opens sec.gov)
Sep 124
Burstein Jennifer0001567619-19-018223
SEC(opens sec.gov)
Feb 154
Burstein Jennifer0001567619-19-004567
SEC(opens sec.gov)
Jan 24
Burstein Jennifer0001567619-19-000103
SEC(opens sec.gov)
Dec 124
Burstein Jennifer0001567619-18-007785
SEC(opens sec.gov)

Companies

Address

C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVENUE

BEDFORD, MA, 01730